BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 398103)

  • 1. [Current problems of BCG innoculation of newborns and children].
    Habedank M
    Z Geburtshilfe Perinatol; 1979 Dec; 183(6):393-5. PubMed ID: 398103
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional lymphadenitis following BCG vaccination (BCGitis). Clinical comments based upon 25 instances among 1295 childhood vaccinees.
    Chaves-Carballo E; Sanchez GA
    Clin Pediatr (Phila); 1972 Dec; 11(12):693-7. PubMed ID: 4639315
    [No Abstract]   [Full Text] [Related]  

  • 3. BCG vaccination of neonates, infants, schoolchildren and adolescents. Part II: Safety of a vaccine with strain 1331 Copenhagen.
    Lehmann HG; Engelhardt H; Freudenstein H; Hennessen W; Quast U; Widmark RM
    Dev Biol Stand; 1979; 43():133-6. PubMed ID: 520665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors in the development of complications after BCG vaccination].
    Kozlova AV
    Probl Tuberk; 1984 Aug; (8):15-9. PubMed ID: 6494116
    [No Abstract]   [Full Text] [Related]  

  • 5. Is medical therapy effective for regional lymphadenitis following BCG vaccination?
    Caglayan S; Yegin O; Kayran K; Timocin N; Kasirga E; Gun M
    Am J Dis Child; 1987 Nov; 141(11):1213-4. PubMed ID: 3673975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Follow-up studies of children who had postvaccination lymphadenitis].
    Gaĭtnietse RIa; Kratule RV
    Probl Tuberk; 1990; (9):32-4. PubMed ID: 2274506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adverse event after BCG vaccination in Poland in the years 1994-1997].
    Szczuka I
    Pneumonol Alergol Pol; 1999; 67(5-6):208-16. PubMed ID: 10570642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Bacillus Calmette-Guérin-associated lymphadenitis.
    Oğuz F; Müjgan S; Alper G; Alev F; Neyzi O
    Pediatr Infect Dis J; 1992 Oct; 11(10):887-8. PubMed ID: 1408492
    [No Abstract]   [Full Text] [Related]  

  • 9. Exaggerated BCG lymphadenitis: clinical profile.
    Sharma DB; Lahori UC
    Indian J Pediatr; 1979 Sep; 46(380):312-20. PubMed ID: 528025
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunity status in children with Bacille Calmette-Guerin adenitis. A prospective study in Tehran, Iran.
    Samileh N; Ahmad S; Farzaneh A; Shahnaz R; Lida F; Mohammad N
    Saudi Med J; 2006 Nov; 27(11):1719-24. PubMed ID: 17106549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative evaluation of the effectiveness of vaccination of newborn infants with BCG and BCG-M vaccines].
    Mitinskaia LA; Demeshko ND; Efimova AA; Litseva OA; Iablokova TB; Levi DT; Pisarenko NN; Kogan ES
    Probl Tuberk; 1990; (12):3-5. PubMed ID: 2084688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse events following BCG vaccination in infants and children up to 36 months of age].
    Gołebiowska M; Andrzejewska E; Stryjewska I; Baranowska H; Drazkiewicz A
    Przegl Epidemiol; 2008; 62(1):71-5. PubMed ID: 18536227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [BCG vaccination and increasing the effectiveness of treatment of post-vaccination complications by the use of rifampicin and dimexide].
    Mitinskaia LA; Iukhimenko NV; Kamaeva VF
    Probl Tuberk; 1994; (5):4-7. PubMed ID: 7870725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complications of BCG vaccination in young children].
    Agzamov RA; Zakharova RI; Aĭbekova MK
    Probl Tuberk; 1983 Mar; (3):14-6. PubMed ID: 6856599
    [No Abstract]   [Full Text] [Related]  

  • 15. The importance of antituberculous vaccination in later phases of a successful antituberculous programme.
    Krebs A
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):425-31. PubMed ID: 1239469
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical characteristics and treatment of the complications of antituberculosis inoculations in children and adolescents].
    Pilipchuk NS; Tonkovid EM
    Probl Tuberk; 1982 Jul; (7):55-8. PubMed ID: 7134210
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
    Szczuka I
    Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of post-BCG lymphadenitis.
    Bhandari B; Khurana R; Mandowara SL
    Indian J Pediatr; 1980; 47(388):367-70. PubMed ID: 7228236
    [No Abstract]   [Full Text] [Related]  

  • 19. BCG lymphadenitis.
    Ali S; Almoudaris M
    Arch Dis Child; 2004 Sep; 89(9):812. PubMed ID: 15321853
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical aspect and therapy of BCG-lymphadenitis (author's transl)].
    Lachmann D; Howanietz L
    Padiatr Padol; 1976; 11(1):283-6. PubMed ID: 1250626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.